February 1, 2019 · Biotechnology, Entrepreneurs, Finance, People

Recently, Marc Beer successfully raised $42 million in Series B Round and venture debt for Renovia Inc, a Boston-based women’s health startup. The funds will help the medtech company to move forward with its several new products for treatment of pelvic floor disorders. Mr. Beer closed $32 million in Series B Round as well as $10 million in venture debt for Renovia Inc.


The company has been committed to the development of therapeutic and diagnostic products for treatment of pelvic floor disorders since its inception. Pelvic floor disorders such as urinary incontinence affects millions of women across the world. The move by Marc Beer with other co-founders to take the fight to the next level through Renovia is very welcome. The first Renovia’s product to be approved by FDA is the Leva Device. It was approved last year April.


The Longwood Fund is a healthcare-focused investment firm which took interest and invested in Renovia Inc, early. It also participated in the Series B Round which was led by Ascension Ventures as well as Perceptive Advises which are based in Missouri and New York respectively. The funding came at a time the company was looking to develop four therapeutic and diagnostic products including the latest upgrade for Leva Device.


In a statement, Marc Beer was thrilled to get the support of leading healthcare investors who share the same vision of better diagnosing, treating as well as improving the lives over 250 million women affected by pelvic floor disorder across the world. He added that the company leverages on its innovative and proprietary technologies, a digital platform as well as form factors to inform new treatment options, drive greater knowledge and ultimately improve the understanding of pelvic floor disorders. The aim at the long-run is to reduce the healthcare costs.


Marc Beer is the CEO of Renovia Inc, and a big name in the healthcare industry. He has brought a lot of transformations to the sector and he has improved the lives of many directly or indirectly. He embarked on a new path with Renovia to alleviate the suffering of women across the world.


About Marc Beer


Mr. Marc Beer brings over 25 years of experience in the biotechnology, devices, pharmaceuticals as well as diagnostics. He embarked on a journey to improve the lives of women through Renovia with Yolanda Lorie and Ramon Iglesias. He successfully closed Series A Round with popular healthcare venture capital funds. He has extensive experience ranging from serving as a strategic consultant at OvaScience to founding various medtech companies including ViaCell.


He founded ViaCell in 2000 to collect, preserve, and develop umbilical cord blood stem cells. He headed the company and helped it to grow until it was acquired by PerkinElmer in 2007. He served at Erytech Pharma as a member of board of directors. He also worked at Genzyme, Abbott Laboratories and Good Start Genetics, Inc. He sits in various committees and boards at Good Start Genetics, Inc, and Minerva Neurosciences. He is a BS graduate from Miami University in Ohio. Learn more: https://patch.com/massachusetts/boston/renovias-marc-beer-raises-42m-treat-womens-health-issues


Written by

Leave a Reply

XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>